SRDX stock forecast
Our latest prediction for SurModics, Inc.'s stock price was made on the Dec. 2, 2019 when the stock price was at 40.70$.
In the short term (2weeks), SRDX's stock price should underperform the market by -3.89%. During that period the price should oscillate between -6.76% and +5.15%.
In the medium term (3months), SRDX's stock price should underperform the market by -8.49%. During that period the price should oscillate between -22.24% and +11.45%.Get email alerts
About SurModics, Inc.
SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
At the moment the company generates 100M USD in revenues.
On its last earning announcement, the company reported a profit of 0.55$ per share.
The book value per share is 8.14$
Three months stock forecastDec. 2, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|